Propel Bio Management »

Applied Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $31M 6.6M 4.67
2024-03-31 $42M 6.1M 6.80
2023-12-31 $18M 5.4M 3.35

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Applied Therapeutics

VR Adviser
Perceptive Advisors
Henderson Group
BlackRock
Franklin Resources
BlackRock
Propel Bio Management
Knoll Capital Management
Vanguard Group
Deutsche Bank Aktiengesellschaft
Morgan Stanley
Simplify Asset Management
Tang Capital Management
Geode Capital Management
Stempoint Capital

View all funds holding Applied Therapeutics